# Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

> **NCT01491711** · PHASE4 · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 162 (estimated)

## Conditions studied

- Superficial Basal Cell Carcinoma

## Interventions

- **DRUG:** Methylaminolevulinate PDT in 2 sessions
- **DRUG:** Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT

## Key facts

- **NCT ID:** NCT01491711
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491711, "Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01491711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*